Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.
Nejadmoghaddam MR, Zarnani AH, Ghahremanzadeh R, Ghods R, Mahmoudian J, Yousefi M, Nazari M, Ghahremani MH, Abolhasani M, Anissian A, Mahmoudi M, Dinarvand R.
Nejadmoghaddam MR, et al. Among authors: dinarvand r.
Sci Rep. 2017 Oct 17;7(1):13373. doi: 10.1038/s41598-017-13682-9.
Sci Rep. 2017.
PMID: 29042604
Free PMC article.